Enrique A. Conterno
2011
In 2011, Enrique A. Conterno earned a total compensation of $3.7M as Senior Vice President and President, Lilly Diabetes at Lilly Eli & Co, a 3% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $887,380 |
|---|---|
| Non-Equity Incentive Plan | $624,609 |
| Salary | $666,250 |
| Stock Awards | $1,500,000 |
| Other | $39,975 |
| Total | $3,718,214 |
Conterno received $1.5M in stock awards, accounting for 40% of the total pay in 2011.
Conterno also received $887.4K of change in pension value and nonqualified deferred compensation earnings, $624.6K in non-equity incentive plan, $666.3K in salary and $40K in other compensation.
Rankings
In 2011, Enrique A. Conterno's compensation ranked 1,610th out of 10,747 executives tracked by ExecPay. In other words, Conterno earned more than 85.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,610 out of 10,747 | 85th |
Division Manufacturing | 582 out of 3,960 | 85th |
Major group Chemicals And Allied Products | 127 out of 1,038 | 88th |
Industry group Drugs | 72 out of 786 | 91st |
Industry Pharmaceutical Preparations | 60 out of 571 | 90th |
Source: SEC filing on March 24, 2014.
Conterno's colleagues
We found five more compensation records of executives who worked with Enrique A. Conterno at Lilly Eli & Co in 2011.
2011
John Lechleiter
Lilly Eli & Co
Chief Executive Officer
2011
Bryce Carmine
Lilly Eli & Co
Retired Executive Vice President and President, Lilly Bio-Medicines
2011
Derica Rice
Lilly Eli & Co
Chief Financial Officer
2011
Jan Lundberg
Lilly Eli & Co
Executive Vice President, Science and Technology and President, Lilly Research Laboratories
2011
Robert Armitage
Lilly Eli & Co